[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Conditions](https://durgical.com/en/conditions/) › Drug-induced lung disease

# Drug-induced lung disease

Lung inflammation or scarring caused by a medicine, such as some heart, cancer, rheumatology or antibiotic drugs. Stopping the drug is the key step.

Updated Nov 15, 2026

On this page

- The basics What it is
- How to think about it
- Who gets it
- Causes
- Risk factors
- Pathophysiology
- Classification
- Which drug, which lung picture?
- Common traps
- Why it happens

- Clinical Symptoms and signs
- Red flags
- Diagnosis
- Differential diagnosis
- Complications
- Prognosis

- Treatment Goal of treatment
- Treatment

- Study Test yourself

- Connections Connections

## What it is

Injury to the lung parenchyma, airways, [pleura](https://durgical.com/en/anatomy/pleura/) or pulmonary vessels caused by a medication. It can take almost any interstitial pattern, from hypersensitivity and organizing pneumonia to fibrosis or [diffuse alveolar damage](https://durgical.com/en/general-pathology/diffuse-alveolar-damage/), and is diagnosed by exclusion and by its link in time to the drug.

## How to think about it

Check the medicine list before the differential: almost any lung pattern can be a drug. The proof is time and withdrawal: the drug came before the lung changed, nothing else explains it, and the lung improves when the drug stops.

See it in 3D

- [Right lower lobe](https://durgical.com/en/anatomy/inferior-lobe-of-right-lung/)
- [Left lower lobe](https://durgical.com/en/anatomy/inferior-lobe-of-left-lung/)
- [Pleura](https://durgical.com/en/anatomy/pleura/)
- [Segmental bronchi](https://durgical.com/en/anatomy/segmental-bronchus/)

## +3

- [Pulmonary arteries](https://durgical.com/en/anatomy/right-pulmonary-artery/)
- [Right ventricle](https://durgical.com/en/anatomy/right-ventricle/)
- [Pericardium](https://durgical.com/en/anatomy/pericardium/)

## Who gets it

Accounts for a few per cent of all [interstitial lung disease](https://durgical.com/en/conditions/interstitial-lung-disease/), more with the growth of cancer immunotherapy and targeted drugs. Hundreds of drugs have been implicated (the Pneumotox database lists them). Risk is highest in older adults, people with existing lung disease and those receiving several toxic drugs or chest radiation.

## Causes

- Cardiovascular: [amiodarone](https://durgical.com/en/pharmacology/amiodarone/) (dose- and duration-related)
- Chemotherapy: [bleomycin](https://durgical.com/en/pharmacology/bleomycin/), [busulfan](https://durgical.com/en/pharmacology/busulfan/), [cyclophosphamide](https://durgical.com/en/pharmacology/cyclophosphamide/), [gemcitabine](https://durgical.com/en/pharmacology/gemcitabine/), taxanes
- [Immune checkpoint inhibitors](https://durgical.com/en/pharmacology/classes/immune-checkpoint-inhibitors/) (anti-PD-1, anti-PD-L1, anti-CTLA-4): pneumonitis
- Disease-modifying antirheumatic drugs and biologics: [methotrexate](https://durgical.com/en/pharmacology/methotrexate/), [leflunomide](https://durgical.com/en/pharmacology/leflunomide/), anti-TNF agents
- Antimicrobials: [nitrofurantoin](https://durgical.com/en/pharmacology/nitrofurantoin/) (acute and chronic forms), [minocycline](https://durgical.com/en/pharmacology/minocycline/), [daptomycin](https://durgical.com/en/pharmacology/daptomycin/) ([eosinophilic pneumonia](https://durgical.com/en/conditions/eosinophilic-pneumonias/))
- Targeted therapies such as [mTOR inhibitors](https://durgical.com/en/pharmacology/classes/mtor-inhibitors/) and EGFR [tyrosine](https://durgical.com/en/biochemistry/molecules/tyrosine/) [kinase inhibitors](https://durgical.com/en/pharmacology/classes/kinase-inhibitors/); also illicit drugs ([cocaine](https://durgical.com/en/pharmacology/cocaine/), heroin)

## Risk factors

- Older age
- Pre-existing lung disease, especially interstitial disease
- High cumulative dose or long duration (amiodarone, bleomycin)
- Combined chemotherapy, chest [radiotherapy](https://durgical.com/en/nursing/radiation-therapy-skin-care-fatigue-and-safety-with-implants-and-radioactive-sou/) or high inspired [oxygen](https://durgical.com/en/pharmacology/oxygen/) (bleomycin)
- Reduced [kidney](https://durgical.com/en/anatomy/kidney/) function (bleomycin is cleared by the kidney)
- Smoking

## Pathophysiology

Drug exposure → one of four kinds of injury: direct oxidant cytotoxicity to epithelium and endothelium (bleomycin, made worse by high inspired oxygen), [phospholipid](https://durgical.com/en/biochemistry/topics/phospholipids/) build-up in macrophages and pneumocytes (amiodarone), immune hypersensitivity (methotrexate, nitrofurantoin), or T cells released from their brakes by checkpoint blockade → inflammation, leak or scarring that shows as [a pattern](https://durgical.com/en/conditions/a-and-v-pattern-strabismus/): NSIP, organizing pneumonia, [hypersensitivity pneumonitis](https://durgical.com/en/conditions/hypersensitivity-pneumonitis/), eosinophilic pneumonia, diffuse alveolar damage, alveolar haemorrhage or fibrosis → an early fall in [DLCO](https://durgical.com/en/physiology/diffusion-across-the-respiratory-membrane-and-dlco/), then restriction and hypoxaemia. One drug can cause several patterns, so the pattern does not name the drug.

## Classification

- By pattern: hypersensitivity, organizing pneumonia, eosinophilic pneumonia, nonspecific interstitial pneumonia, diffuse alveolar damage or [ARDS](https://durgical.com/en/conditions/acute-respiratory-distress-syndrome/), alveolar haemorrhage, pulmonary fibrosis
- Other sites: bronchospasm ([beta blockers](https://durgical.com/en/pharmacology/classes/beta-blockers/), [aspirin](https://durgical.com/en/pharmacology/acetylsalicylic-acid/)), [pleural effusion](https://durgical.com/en/conditions/pleural-effusion/) (drug-induced lupus), [pulmonary hypertension](https://durgical.com/en/general-pathology/pulmonary-hypertension/) (some anorexigens, [dasatinib](https://durgical.com/en/pharmacology/dasatinib/)), pulmonary oedema (opioids, [cytarabine](https://durgical.com/en/pharmacology/cytarabine/))
- By timing: acute (hours to weeks) or chronic (months to years, sometimes after the drug was stopped)
- Immune checkpoint inhibitor pneumonitis graded 1 to 4 by severity

## Symptoms and signs

- Dry cough
- Progressive or sudden [breathlessness](https://durgical.com/en/physiology/hypercapnia-and-dyspnea-what-excess-co-does-and-why-breathlessness-is-felt/)
- Fever, sometimes with rash or eosinophilia (hypersensitivity forms)
- Chest discomfort or [pleuritic pain](https://durgical.com/en/conditions/pleurisy/)
- Crackles on examination
- In chronic forms, slow decline that may be mistaken for the underlying disease

## Red flags

- Hypoxaemia at rest or rapid progression (diffuse alveolar damage)
- New infiltrates in a patient on checkpoint inhibitors (pneumonitis can be fatal)
- [Haemoptysis](https://durgical.com/en/conditions/haemoptysis/) with falling haemoglobin (alveolar haemorrhage)
- Fever and infiltrates on immunosuppression (infection must be excluded)
- Symptoms despite stopping the drug

## Diagnosis

**Clinical**
A diagnosis of exclusion based on exposure to a drug known to injure the lung, a compatible time course, a compatible pattern, exclusion of infection, [heart failure](https://durgical.com/en/conditions/heart-failure/) and progression of the underlying disease, and improvement after stopping the drug. A full drug history includes past chemotherapy, herbal products and illicit drugs.

**Tests**
Lung function (falling DLCO is an early sign, used to monitor bleomycin and amiodarone). Blood count for eosinophilia. [Bronchoscopy](https://durgical.com/en/clinical-skills/bronchoscopy/) with lavage mainly excludes infection; lymphocytosis suggests hypersensitivity, eosinophilia suggests eosinophilic pneumonia, and haemosiderin-laden macrophages suggest haemorrhage. Biopsy is seldom needed.

**Imaging**
[Chest](https://durgical.com/en/anatomy/region/chest/) X-ray and high-resolution CT show the pattern: ground glass, consolidation, reticulation or diffuse alveolar damage. With amiodarone, dense (high-attenuation) consolidations and a dense [liver](https://durgical.com/en/anatomy/liver/) on CT reflect [iodine](https://durgical.com/en/biochemistry/topics/iodine/) accumulation. Echocardiography if heart failure or pulmonary hypertension is a possibility.

## Differential diagnosis

- Pneumonia and opportunistic infections ([Pneumocystis](https://durgical.com/en/microbiology/pneumocystis-jirovecii/), [cytomegalovirus](https://durgical.com/en/microbiology/cytomegalovirus/))
- Cardiogenic pulmonary oedema
- Progression of the cancer (lymphangitic [spread](https://durgical.com/en/epidemiology/change-management-making-improvements-stick/)) or of the underlying rheumatic disease
- Radiation pneumonitis
- Idiopathic interstitial pneumonias
- [Pulmonary embolism](https://durgical.com/en/conditions/pulmonary-embolism/)

## Which drug, which lung picture?

| Drug | Typical timing | Main patterns | Clue |
| --- | --- | --- | --- |
| Amiodarone | Months to years; risk grows with cumulative exposure | NSIP, organizing pneumonia, fibrosis | Dense (high-attenuation) consolidation and a dense liver on CT |
| Bleomycin | During or after chemotherapy; higher risk with age, kidney impairment and high oxygen | Fibrosis, diffuse alveolar damage | Falling DLCO; worsened by high inspired oxygen |
| Methotrexate | Usually in the first months to year | Hypersensitivity pneumonitis | Fever, cough, sometimes eosinophilia; exclude Pneumocystis |
| Nitrofurantoin | Acute (days: fever, eosinophilia) or chronic (months to years) | Acute hypersensitivity; chronic NSIP or fibrosis | Older woman on long-term prophylaxis for urinary infection |
| Immune checkpoint inhibitors | Weeks to months after starting | Organizing pneumonia, NSIP, hypersensitivity-like | Other immune adverse events (colitis, [thyroiditis](https://durgical.com/en/conditions/thyroiditis/), hepatitis) |

## Goal of treatment

Recognise the injury early, stop the causative drug and avoid re-exposure, support breathing, and use [corticosteroids](https://durgical.com/en/pharmacology/classes/corticosteroids/) when the injury is significant.

## Treatment

**Medical**
Stop the suspected drug and avoid re-challenge with it (and close relatives) in serious reactions; record it as an adverse reaction and report it to [pharmacovigilance](https://durgical.com/en/nursing/pharmacovigilance-and-technovigilance-what-nurses-report/).

**Medical**
Systemic corticosteroids for moderate or severe injury, especially hypersensitivity, organizing pneumonia, eosinophilic pneumonia and checkpoint inhibitor pneumonitis; additional immunosuppression for steroid-refractory immunotherapy pneumonitis.

**Acute**
Oxygen and ventilatory support in acute severe forms; lowest effective inspired oxygen after bleomycin exposure.

**Rehabilitation**
Pulmonary rehabilitation and oxygen when fibrosis persists.

**Follow-up**
Baseline and periodic lung function, imaging and symptom review in patients on high-risk drugs; multidisciplinary review before any re-challenge (for example low-grade immunotherapy pneumonitis).

## Complications

- [Acute respiratory failure](https://durgical.com/en/conditions/acute-respiratory-failure/) and ARDS
- Permanent pulmonary fibrosis
- Pulmonary hypertension
- Loss of effective cancer or rheumatology treatment when the drug must be stopped
- Corticosteroid side effects and opportunistic infections

## Common traps

- **A typical drug pattern proves the drug**: every pattern has other causes; infection, heart failure and progression of the underlying disease are excluded first
- **A drug taken safely for years cannot be the cause**: amiodarone and nitrofurantoin toxicity often appear after months to years, and bleomycin injury can be unmasked by oxygen long after treatment
- **New infiltrates on immunotherapy are always infection**: checkpoint inhibitor pneumonitis is common and treated with corticosteroids, while infection is excluded in parallel
- **High-flow oxygen is harmless after bleomycin**: high inspired oxygen can precipitate toxicity; use the lowest oxygen that keeps saturation in the target range
- **Stopping the drug is all the treatment needed**: improvement after withdrawal supports the diagnosis, but moderate or severe injury also needs corticosteroids

## Prognosis

Most hypersensitivity and organizing pneumonia patterns improve after stopping the drug, with or without corticosteroids. Diffuse alveolar damage and established fibrosis (bleomycin, busulfan, amiodarone) carry high mortality. Early recognition is the main factor that improves outcomes.

## Test yourself

Think of the answer, then tap the question to see it.

## Which test is an early marker of lung toxicity in patients on bleomycin or amiodarone?

A fall in diffusing capacity (DLCO) on lung function testing.

## Why is high inspired oxygen avoided in patients exposed to bleomycin?

Oxygen increases oxidant injury and can precipitate or worsen bleomycin lung toxicity, even years later.

## What CT finding suggests amiodarone lung toxicity?

High-attenuation (dense) consolidations, often with a dense liver, because of the iodine in amiodarone.

## Which new class of cancer drugs commonly causes pneumonitis?

Immune checkpoint inhibitors (anti-PD-1, anti-PD-L1, anti-CTLA-4); pneumonitis is graded and treated with corticosteroids.

## A 74-year-old on amiodarone for 2 years has 2 months of dyspnoea and dry cough. CT: dense peripheral consolidations and a dense liver; infection and heart failure excluded. Cause and first step?

Amiodarone toxicity (its iodine makes lung and liver dense). Stop it, choosing another rhythm strategy with cardiology, and add corticosteroids if moderate or severe; recovery is slow.

[Add to my cards (5)](https://durgical.app/estudiar/?add=/en/conditions/drug-induced-lung-disease/)

## Why it happens

- [Drug- and radiation-induced lung injury](https://durgical.com/en/general-pathology/drug-and-radiation-induced-lung-injury/)

## Connections

## In physiology 1

- [Diffusion across the respiratory membrane and DLCO](https://durgical.com/en/physiology/diffusion-across-the-respiratory-membrane-and-dlco/)

## Related conditions 13

- [Interstitial lung disease](https://durgical.com/en/conditions/interstitial-lung-disease/)
- [Hypersensitivity pneumonitis](https://durgical.com/en/conditions/hypersensitivity-pneumonitis/)
- [Eosinophilic pneumonias (including Löffler syndrome)](https://durgical.com/en/conditions/eosinophilic-pneumonias/)
- [Cryptogenic organizing pneumonia](https://durgical.com/en/conditions/cryptogenic-organizing-pneumonia/)
- [Acute respiratory distress syndrome (ARDS)](https://durgical.com/en/conditions/acute-respiratory-distress-syndrome/)
- [Diffuse alveolar haemorrhage](https://durgical.com/en/conditions/diffuse-alveolar-haemorrhage/)
- [Pleural effusion](https://durgical.com/en/conditions/pleural-effusion/)
- [Pulmonary hypertension and cor pulmonale](https://durgical.com/en/conditions/pulmonary-hypertension-and-cor-pulmonale/)
- [Cutaneous drug reactions and DRESS](https://durgical.com/en/conditions/cutaneous-drug-reactions-and-dress/)
- [Systemic lupus erythematosus](https://durgical.com/en/conditions/systemic-lupus-erythematosus/)
- [Pneumocystis pneumonia (PCP)](https://durgical.com/en/conditions/pneumocystis-pneumonia/)
- [Idiopathic pulmonary fibrosis](https://durgical.com/en/conditions/idiopathic-pulmonary-fibrosis/)

## See all 13

- [Connective tissue disease–associated interstitial lung disease](https://durgical.com/en/conditions/connective-tissue-disease-associated-interstitial-lung-disease/)

Educational information, not medical advice. For any symptom, see a health professional.

Sources: [Interstitial Lung Disease](https://www.ncbi.nlm.nih.gov/books/NBK541084/) (StatPearls (NCBI Bookshelf), 2026); [Amiodarone](https://www.ncbi.nlm.nih.gov/books/NBK482154/) (StatPearls (NCBI Bookshelf), 2023); [Bleomycin](https://www.ncbi.nlm.nih.gov/books/NBK555895/) (StatPearls (NCBI Bookshelf), 2023).

[← All conditions](https://durgical.com/en/conditions/)

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/conditions/drug-induced-lung-disease/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/conditions/drug-induced-lung-disease/
